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Human T-lymphotropic virus type I is associated with adult T-cell leukaemia/lymphoma and with HTLVassociated myelopathy. 1 " 3 Serological surveys have revealed HTLV-I antibody prevalence ranging from 3% to 15% in southern Japan, several Caribbean nations, and Africa, 4 and seroprevalence is increased in women and in the elderly. HTLV-I is transmitted from mother to child predominantly by breastfeeding, 5 from men to women and to a lesser degree from women to men by sexual intercourse 6 " 9 and by transfusion of infected blood. 10 " 11 Except for maternal-child and blood transfusion, the known modes of HTLV-I transmission are not well quantified, and they may not explain all aspects of the epidemiology of this virus. Modelling of HTLV-I transmission using parameters for transmission efficacy derived from published studies in Jamaica yielded ageand sex-specific prevalences that were lower than measured rates. 12 In addition, elevated HTLV-I seroprevalence has been found at low altitudes in both Jamaica and Colombia 13 ' 14 in proximity to watercourses," and in farmers and fishermen 161 ' 7 suggesting potential environmental vectors of HTLV transmission. We therefore performed a case-control analysis of risk factors for viral infection during the enrolment visit of a large cohort of HTLV-I seropositives and seronegatives. A separate report describes health effects measured at the same enrolment visit. 18 
METHODS

Study Population
In 1985-1986, over 13 000 food service licence applicants from all 13 Jamaican parishes (counties) of the island were screened for HTLV-I antibody. The methods and results of this large serosurvey have been described in detail elsewhere. 15 Of 13 260 subjects in the initial serosurvey, 806 (6.1%) were seropositive for HTLV-I on the basis of either confirmed Western blot serology or high enzyme-linked immunosorbent assay (ELISA) absorbance values, since Western blot was not done on all positives. Because it was logistically impossible to re-examine all seropositives, the nested case-control study was limited to three Jamaican parishes representing both urban and rural environments. All seropositives from the contiguous urban parishes of Kingston and St Andrew, and from the rural parish of Clarendon, were selected for enrolment.
An equal number of control subjects was selected from the same 1985-1986 sample of food service licence applicants. They were negative for HTLV-I antibodies, and were frequency matched by 10-year age group, sex, and parish with the cohort of HTLV-I seropositives. Both seropositives and controls were contacted by means of letter, telegram or visit and asked to come to a central clinic. Following written informed consent, they were interviewed, examined, and a blood sample was drawn between 26 January 1987 and 26 April 1988. The interview and examination was blinded as to HTLV-I status, but at the end of the visit the subjects were informed of their test results. The HTLV-I seropositives were given information on possible health effects of HTLV-I, and were counselled on ways to prevent secondary transmission of the virus. The study protocol was approved by the relevant review committees of the National Cancer Institute, the University of the West Indies, and the Jamaican Ministry of Health.
Laboratory Testing
Serological testing for the 1987-1988 follow-up was performed using an ELISA (Dupont, Wilmington DE). The ELISA positives were confirmed using a Western immunoblot (Cambridge Biotech, Rockville MD) containing a mixture of disrupted HTLV-I whole virus and recombinant p21e envelope protein. A seropositive result required a positive ELISA and bands corresponding to both gag and env reactivity on the p21e Western blot (either pl9 or p24 plus either gp46 or p21e). Seronegativity was defined as either a negative ELISA or a positive ELISA and no bands on Western blot. Indeterminate samples had positive ELISA and at least one band on p21e Western blot but failed to meet the criteria for positivity. Any subjects with results that differed from their 1985-1986 serology had both specimens retested by both 1987-1988 ELISA and Western blot.
Statistical Analysis
For categorical variables, the frequency of each response was compared between seropositives and controls using crosstabulation functions of a statistical software package (SAS, Cary NC). Odds ratio (OR) and 95% confidence interval (CI) were calculated using Woolf's method. The % 2 test for trend was used when appropriate. For the analysis of lifetime male sexual partners among female subjects, eight seropositive and eight seronegative women responded '<5' rather than providing the desired enumeration, and these 16 subjects were excluded from Table 2A . Rare responses of >5 lifetime male partners were recoded as 5 in constructing the logistic regression variable. Multivariate analyses were performed using the SAS PROC LOGIST procedure.
RESULTS
Study Population
Of the 284 seropositives and 284 controls chosen for enrolment, 89 subjects could not be located despite several attempts using address data from the initial screening or contact with next of kin or neighbours. Sixteen had migrated out of Jamaica, 19 refused to enter this follow-up study, and four (three HTLV-I seropositive and one seronegative) had died in the interval between the two studies. A total of 440 subjects were enrolled. Enrolment rates did not differ significantly by status as positive or control, nor by location (79% for Kingston/St Andrew and 74% for Clarendon). Four subjects (one Kingston/St Andrew and three Clarendon) were interviewed and examined but either refused blood drawing or had lost or broken specimen tubes, and were excluded from the analysis because their HTLV-I status could not be verified. There were occasional inconsistencies between results of the 1985-1986 and the 1987-1988 testing; for the risk factor analyses, HTLV-I status was defined by the latter result. Ten subjects were excluded because of indeterminate Western blot patterns in this testing.
The age and sex distributions of the final study population of 426 are given in Table 1 . There were 201 subjects in the HTLV-I seropositive group and 225 subjects 
Risk Factors for HTLV-1 Infection
Analysis of risk factors for HTLV-I infection revealed that HTLV-I seropositives had significantly more lifetime sexual partners than did the age-and sex-matched control group. Female subjects (Table 2A) reported a median of three lifetime sexual partners, and the OR for HTLV-I seropositivity increased directly with the number of lifetime sexual partners, with a significant test for trend (x 2 trend = 5.44, P < 0.05). Re-analysis with apportionment of the 16 excluded women into the 1-4 partner categories according to the overall distribution of women with four or fewer partners did not substantially change the results {% 2 = 5.75, P < 0.05). The prevalence of HTLV-I seropositivity was also correlated with the higher number of 'babyfathers' (men fathering a child with the woman) reported by the female subjects, although the trend test was of borderline significance.
The type of contraceptive used by female subjects was related to HTLV-I seropositivity (Table 2A) . Only 39 (14% of the 280 women who were sexually active during the past 5 years reported that condoms were used at least once a month during intercourse, and the median frequency of use was between one and two times per month. There was no significant relation of condom use to HTLV-I status, although the OR estimate for use once or more per month was slightly below unity. In contrast, use of an intrauterine device (IUD) for at least one year was associated with HTLV-I seropositivity (OR = 2.67, 95% CI : 1.13-6.32). Birth control pill and Depo-Provera use resulted in OR of subjects. An additional eight HTLV seropositive and eight seronegative subjects were excluded from the Table because they responded '<5' without further clarification.
1.24 and 1.26, respectively for HTLV-I seropositivity, although CI did not exclude unity for either estimate. Logistic regression analysis was used to determine if the IUD association was independent or confounded by sexual activity. A model containing IUD use and the number of lifetime male sexual partners treated as a numerical variable was applied to female subjects only. Both IUD use (OR = 2.55, 95% CI : 1.07-6.07) and the number of male lifetime partners (OR = 1.21 per partner, 95% CI : 1.02-1.44) were independently associated with HTLV-I seropositivity in the logistic model. Men reported a median of 5-10 lifetime sexual partners, and the broader distribution of male responses allowed the inclusion of most men in a single categorical analysis (Table 2B ). Relative to number of lifetime partners, the calculated OR were lower than those for women, but a positive trend for HTLV-I seropositivity with increasing number of lifetime sexual partners was found (x 2 trend = 4.36, P < 0.05). Only one man admitted to having sex with another man; he was an HTLV-I seropositive who reported a bisexual orientation with a lifetime total of two male sexual partners and four female partners. A non-significant protective effect of using condoms at least once per month was observed; however, less than a third of the men used a condom even this frequently.
Other personal risk factors previously shown to be associated with HTLV-I infection were examined (Table 3) . Of the seropositives, 97% had been breastfed, compared to 93% of the seronegatives, an insignificant difference. Only one seronegative subject admitted to prior intravenous drug abuse, however, self-reported marijuana use was slightly more common among the HTLV-I seropositives. A history of blood transfusion was more common among the seropositive group than among the seronegatives, although the association failed to reach statistical significance. Neither the level of educational attainment, occupational category nor weekly income was associated with HTLV-I seropositivity.
Several environmental factors were examined (Table  4) . No differences in childhood (specifically, age 10) or current residential exposure to mosquito or tick bites was observed, nor in occupational or domestic contact with various animals, their meat, or their excreta. No association between HTLV-I seropositivity and proximity of the subjects' childhood or current residence to rivers, lakes, canals, or the sea was observed. More HTLV-I seropositives than seronegatives reported childhood and current residence within 100 yards of a swamp or marsh, although the number of such subjects was small and no significant association with HTLV-I status could be documented.
DISCUSSION
We report a cross-sectional analysis of risk factor data from the enrolment visit of a cohort study of HTLV-I seropositive Jamaicans and seronegative controls. All subjects were recruited from a previous large HTLV-I serological survey of food service workers, and although the sample was not population based, it is felt to be reasonably representative of working class Jamaican citizens. Our findings confirm that heterosexual intercourse is a major transmission route of HTLV-I, but they do not support the hypothesis that HTLV-I is transmitted by insects or animal vectors. An interesting new observation was the association between HTLV-I seropositivity and IUD use in women.
We have confirmed that a higher number of lifetime sexual partners is a risk factor for HTLV-I seropositivity in both men and women. Kajiyama et al. extrapolated from cross-sectional data to predict a higher transmission efficiency from men to women than vice versa during heterosexual intercourse. 7 Similarly, Murphy et al. reported an association between HTLV-I seropositivity and the number of lifetime sexual partners for women but not for men who attended a Jamaican clinic for sexually-transmitted diseases. 19 In the current study, the association between HTLV-I infection and the number of lifetime partners was stronger for women than for men, further supporting more efficient male-to-female transmission. Frequency matching of cases and controls may have better controlled for confounding by age and aided our detection of the weaker association between lifetime female sexual partners and HTLV-I seropositivity for men. In addition, the current study also showed an association between the number of babyfathers reported by female subjects, strengthening the epidemiological link between multiple sexual partners and HTLV-I infection.
The association between IUD use and HTLV-I seropositivity was unexpected. Review of the literature revealed no other reports of such an association between HTLV-I infection and IUD use; however an Italian study of risk factors for HIV infection found that IUD use was a significant risk factor for HIV seroconversion in the female sexual partners of HIV infected men. 20 Because IUD are associated with an increased frequency of pelvic infections, it may be hypothesized that mucosal alterations or increased lymphocytic infiltration in the cervix or uterus predispose to infection with sexually transmitted retroviruses such as HTLV-I and HIV. Future follow-up of this cohort will be important in confirming the increased risk of HTLV-I infection associated with IUD use. Nevertheless, pending confirmation of this finding, it is prudent to reinforce the public health recommendation that condom use is the preferred prophylactic intervention for couples discordant for HTLV-I infection. 21 The data on contraceptive practices may help to explain differences in HTLV-I age-and sex-specific seroprevalence between Jamaica and Japan. Whereas the use of condoms should theoretically prevent HTLV-I infection, and a small protective effect was seen in this study, this method of contraception was so infrequently used that we had insufficient statistical power to prove such an effect. On the contrary, the IUD and hormonal contraceptives most commonly used in Jamaica were associated with either an increased or neutral risk of HTLV-I infection (Table 2A) . Together with changes in breastfeeding habits, the use of condoms for contraception in Japan since the second world war may be responsible for declining HTLV-I seroprevalence by birth cohort in that country.
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Several other documented risk factors for HTLV-I infection were examined in this study. A history of blood transfusion conferred an OR of 1.69 for HTLV-I seropositivity, although the low number of subjects with a history of blood transfusion was responsible for wide CI that did not exclude unity. In contrast, almost all subjects who could recollect reported that they had been breastfed as infants and individual recall of such information may have been inaccurate. Both the high prevalence and potential misclassification resulted in low statistical power to reject the null hypothesis of no association between breastfeeding and HTLV-I infection. Intravenous drug use is rare in Jamaica; and we suspect that marijuana use may have been underreported, making the non-significant increased OR for marijuana use difficult to interpret.
We were unable to confirm any associations between HTLV-I seropositivity and socioeconomic status or occupation, despite suggestions of such relations in previous studies.
13>l6 - 17 Distributions of educational attainment and income were quite narrow and were almost identical between the positive and negative groups, perhaps reflecting a disadvantage of our occupationally based cohort. Likewise, we did not find any consistent association between HTLV-I infection and occupational or environmental factors such as exposure to insects and animals, or proximity to watercourses. The fact that our positive and negative subjects were well matched in age, sex and socioeconomic status suggests that previously reported associations with occupational or environmental parameters may have been due to confounding by unmeasured variables, especially in those studies with an 'ecologic' design.
Overall, the results of this nested case-control study confirm that sexual transmission is a major mode of transmission of HTLV-I, both from men to women and, to a lesser degree, from women to men. Our results also suggest that women who use IUD are at increased risk of HTLV-I infection. Because the characteristic was either rare or very common, our data are insufficient to prove either the protective effect of condom use or the risk of blood transfusion and breastfeeding in an HTLV-I endemic nation. While it is possible that environmental factors may contribute to HTLV-I seroprevalence, we were unable to demonstrate such associations in this well controlled study. Detailed study of the risk factors of subjects found to be seroconverters in future visits of this cohort may add to these observations or suggest new modes of transmission.
